Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine.
D000728:Androgens / Q000494:pharmacology*; D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002467:Cell Nucleus / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D003687:Dehydroepiandrosterone / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000494:pharmacology; D004958:Estradiol / Q000378:metabolism*; D004965:Estrogen Antagonists; D004970:Estrone / Q000494:pharmacology*; D005260:Female; D006854:Hydrocortisone / Q000494:pharmacology; D006914:Hydroxysteroids / Q000494:pharmacology; D007664:Ketosteroids / Q000494:pharmacology; D008566:Membranes; D009281:Naphthalenes / Q000494:pharmacology; D010539:Permeability; D010636:Phenols / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug; D013739:Testosterone / Q000494:pharmacology; D014316:Tritium; D014599:Uterus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
D000728:Androgens; D000731:Androstanes; D004965:Estrogen Antagonists; D006914:Hydroxysteroids; D007664:Ketosteroids; D009281:Naphthalenes; D010636:Phenols; D011759:Pyrrolidines; D011955:Receptors, Drug; D013196:Dihydrotestosterone; D014316:Tritium; D004970:Estrone; D013739:Testosterone; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; D006854:Hydrocortisone